Small-Cap Investor Forum

[MissionIR]

Celsion (CLSN), Aastrom (ASTM), Ventrus (VTUS), Dendreon (DNDN), Advaxis (ADXS), Others to Present to Investors at Rodman-Renshaw Conference

Biotech company Celsion Corp. is scheduled to present the value case for its drugs to prospective investors at the upcoming Rodman & Renshaw 13th Annual Global Investment Conference. Listed conference presenters, as of Thursday night, numbered more than 200 biotechs for the September 11-13 event, and there are other categories with additional companies.

The conference, organized by full-service investment bankers Rodman & Renshaw, is designed to bring investors and companies together to explore investment possibilities. According to the Rodman website, the company has been ranked by Sagient Research Systems as the top placement agent in terms of the aggregate number of private investment in public equity and registered direct offering financing transactions completed every year since 2005.

Conference presenters will also include Aastrom Biosciences, Inc. (NASDAQ: ASTM), Advaxis, Inc. (OTC BB: ADXS), Dendreon Corp. (NASDAQ: DNDN), and Ventrus Biosciences, Inc. (NASDAQ: VTUS). A full list of biotech presenters is available at http://www.rodmanandrenshaw.com/conferences?id=162&link=presenters.

The conference format is set up as ‘tracks’, eight in all, including tracks for China, metals and mining, energy, technology, cleantech, financial services, and Israel. A complete list of companies and tracks can be found at http://www.rodmanandrenshaw.com/conferences?category&id=162. More than 400 companies in all are expected to present.

In its press release, Celsion said that its CEO Michael H. Tardugno will make the company’s presentation. Celsion is focused on the development and commercialization of anti-cancer drugs and tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. The company has said it will offer a live audio-only webcast of the presentation at their website, and archive it for later listening by interested parties.

Celsion has research, license, or commercialization agreements with various institutions, including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, University of Pisa, and North Shore Long Island Jewish Health System.

The event will also feature such celebrities and public personalities as multi-Grammy-winning artists Natalie Cole and Mary J. Blige, along with former secretary of state Henry Kissinger, former vice president Dick Cheney as keynote speaker, and former senator Christopher Dodd with former SEC chair Harvey Pitt in a discussion panel. Senator Dodd was author of the Dodd-Frank Wall Street Reform bill.

Rodman-Renshaw expects more than 4,000 attendees, drawn mainly from the ranks of private equity firms, institutional investors, sophisticated private investors, industry executives, and business development executives.